These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 5938001)

  • 21. Analysis of neuromuscular transmission failure induced by anticholinesterases.
    Maselli RA; Leung C
    Ann N Y Acad Sci; 1993 Jun; 681():402-4. PubMed ID: 8395155
    [No Abstract]   [Full Text] [Related]  

  • 22. Resistance to the effect of carbachol on the cardiovascular system and on the isolated ileum of rats after subacute administration of an organophosphorus cholinesterase inhibitor.
    McPhillips JJ; Dar MS
    J Pharmacol Exp Ther; 1967 Jun; 156(3):507-13. PubMed ID: 6028878
    [No Abstract]   [Full Text] [Related]  

  • 23. A comparative study of galanthamine hydrobromide and atropine-neostigmine in conscious volunteers.
    Cozanitis DA; Toivakka E
    Anaesthesist; 1971 Nov; 20(11):416-21. PubMed ID: 5126442
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of a cholinesterase inhibitor when injected into the medulla of the rabbit.
    Stewart WC; Anderson EA
    J Pharmacol Exp Ther; 1968 Aug; 162(2):309-18. PubMed ID: 4875330
    [No Abstract]   [Full Text] [Related]  

  • 25. The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis.
    Foldes FF; Smith JC
    Ann N Y Acad Sci; 1966 Jan; 135(1):287-301. PubMed ID: 5221345
    [No Abstract]   [Full Text] [Related]  

  • 26. CNS effects of anticholinesterases in the presence of inhibited cholinesterases.
    Van Meter WG; Karczmar AG; Fiscus RR
    Arch Int Pharmacodyn Ther; 1978 Feb; 231(2):249-60. PubMed ID: 646523
    [No Abstract]   [Full Text] [Related]  

  • 27. Vascular smooth muscle. II. Pharmacology of normal and hypotensive vessels.
    Somlyo AP; Somlyo AV
    Pharmacol Rev; 1970 Jun; 22(2):249-353. PubMed ID: 4393387
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of cholinesterase inhibitors on the neuromuscular blocking action of suxamethonium.
    Valdrighi JB; Fleming NW; Smith BK; Baker GL; White DA
    Br J Anaesth; 1994 Feb; 72(2):237-9. PubMed ID: 8110583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticholinesterase property of oxyfedrine.
    Sakai K; Akima M; Matsushita H
    Arzneimittelforschung; 1972 Jan; 22(1):117-20. PubMed ID: 5066982
    [No Abstract]   [Full Text] [Related]  

  • 30. Further evidence relating to the mode of action of nicotine in the central nervous system.
    Armitage AK; Hall GH
    Nature; 1967 Jun; 214(5092):977-9. PubMed ID: 6055412
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cardiovascular and hemodynamic effects of derivatives of metoclopramide].
    Mouillé P; Cheymol G
    Arch Int Pharmacodyn Ther; 1975 May; 215(1):139-49. PubMed ID: 1156043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Histochemical studies, using the thioacetic acid method, on the inhibition of end-plate esterase by injections of irreversibly active anticholinesterases].
    Jonecko A
    Acta Histochem; 1965 Mar; 20(1):39-44. PubMed ID: 4953905
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cholinesterase inhibitors (anticholinesterases); action mechanism, variations bearing on therapy, and toxicology and treatment of poisoning].
    NAESS K
    Tidsskr Nor Laegeforen; 1956 Feb; 76(4):105-8. PubMed ID: 13311884
    [No Abstract]   [Full Text] [Related]  

  • 34. Further studies on the interaction between acetylcholine antagonists and anticholinesterases on cat soleus muscle.
    Brimblecombe RW; Webb SN
    Br J Pharmacol; 1973 Jun; 48(2):361P-362P. PubMed ID: 4733752
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of cholinesterase inhibitors and reactivators on the blocking action of dicarboxylic acid amino esters on neuromuscular conduction].
    Protas LL; Muske GA; Mndzhoian OL; Danilov AF; Mikhel'son MIa
    Farmakol Toksikol; 1975; 38(3):298-303. PubMed ID: 1227902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Action of Nu-1250 on the arterial pressure of the dog].
    DI STEFANO V
    Arch Fisiol; 1955; 54(4):268-76. PubMed ID: 14388960
    [No Abstract]   [Full Text] [Related]  

  • 37. Antagonism of neuromuscular blockade but not muscle relaxation affects depth of anaesthesia.
    Vasella FC; Frascarolo P; Spahn DR; Magnusson L
    Br J Anaesth; 2005 Jun; 94(6):742-7. PubMed ID: 15778268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of oximes on isolated organs intoxicated with organophosphorus anticholinesterases.
    van der Meer C; Wolthuis OL
    Biochem Pharmacol; 1965 Sep; 14(9):1299-312. PubMed ID: 5857534
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of anti-cholinesterase agents on the rat's blood pressure.
    DIRNHUBER P; CULLUMBINE H
    Br J Pharmacol Chemother; 1955 Mar; 10(1):12-5. PubMed ID: 14351680
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of anticholinesterases on the latencies of action potentials in mouse skeletal muscles.
    Kelly SS; Ferry CB; Bamforth JP
    Br J Pharmacol; 1990 Apr; 99(4):721-6. PubMed ID: 2361169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.